The market for Nano-Silicon Drug Delivery Platforms is categorized according to the product type. This market research report focuses on the global and regional markets. This research report offers insights on key growth and influencing factors for the Nano-Silicon Drug-Delivery Platforms. It also evaluates different methods and industry pioneers in the Nano-Silicon Drug Delivery Platform Market. The report also provides a detailed analysis of the competition in the market. MSNs can be produced in several ways. The most popular method is active targeting, where a silica-based nanoparticle is surface-grafted on a selective cell surface. This type of drug delivery is referred to as ligand-receptor binding. As such, it can be used for several applications. This is a promising way to deliver low-dose drugs to specific sites. Moreover, the product can be manufactured for a variety of purposes.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/45
Other than the biomedical industry, the use of nano-silicon particles in targeted tumor therapies is gaining momentum. Various organizations around the world are studying the potential of using this type of drug delivery in therapeutics. The goal is to develop a nanoparticle-based technology that can deliver medications for weeks or even months at a time. It will revolutionize the pharmaceutical industry, and it will provide affordable targeted drug therapies to patients. In addition to the manufacturing of nano-silicon drugs, the development of new methods of drug delivery using nano-silicon technology is currently being researched by several institutes. For instance, the Icahn School of Medicine at Mount Sinai conducted a clinical trial with gold-silica nanoparticle-based photothermal cancer therapy. Similarly, scientists at the Georgia Institute of Technology reported the development of 200-nanometer silica spheres for drug delivery in certain parts of the body.
Potential Applications
SiSafe will be of significant use to pharmaceutical, animal health, biotech and cosmeceutical companies to formulate and package drugs that are difficult to formulate otherwise. Companies finding better solutions for their existing drugs can incorporate this technology to improve their product quality. Also, new drugs used for chronic diseases can be delivered at a low dose to the target sites with the nano-silicon drug delivery platform.
This new nanotechnology-based drug delivery platform offers competitive advantages such as improved safety, efficacy, controlled release and desired time of onset of drug release. After years of research and development, and extensive capital investment, SiSafe nano-silicon drug delivery platform is ready for commercialization. SiSaf is looking to partner with drug developers who desire to improve their formulation with controlled releases and lower doses. SiSaf received a funding of USD 4.9 million from Singapore’s Vickers Venture Partners and Exen Capital recently in November 2016. This partnership is anticipated to be of great aid for SiSaf to reach more markets globally.
Nano-silicon Drug Delivery Platforms are being used by pharma companies to deliver drugs to patients. SiSafe is used in the manufacture of nanoporous silicon-based microporous materials. Its unique properties enable it to load bioactive cargo through passive adsorption or active anchoring. Moreover, the mesoporous silicon-based nanocarriers have caps that are stimuli responsive, which allows the release of the cargo with control.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/45
Aside from the potential for targeted tumor therapy, nano-silicon particles can also be used for other purposes such as cancer detection. They are currently being studied by different institutions and are expected to revolutionize the pharmaceutical industry. It will be able to deliver drugs for weeks or even months, which is a significant benefit. This technology is a breakthrough in drug delivery and will lead to lower costs for treatments. It is important to note that the nano-silicon particles can also be modified to be highly biodegradable.
Key Developments
Several institutes are focused on R&D related to nano-silicon drug delivery approaches. For instance, in August 2019, researchers from Icahn School of Medicine at Mount Sinai conducted a clinical trial for gold-silica nanoparticles-based photothermal cancer therapy.
Similarly, in June 2019, researchers from Georgia Institute of Technology reported development of silica spheres of around 200 nanometers in size that can be used for drug delivery to eliminate malignant cells only in certain parts of the body, in the journal Angewandte Chemie International Edition.
In March 2018, researchers from the University of South Australia reported the use of an electrospun composite of poly (ε-caprolactone) fibers and porous silicon nanoparticles as an effective system for the tunable delivery of camptothecin, a topoisomerase inhibitor linked to a cyclodextrin-based polymer to form the investigational anti-cancer drug CRLX101.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/45
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Nano-Silicon Drug Delivery Platform Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Nano-Silicon Drug Delivery Platform Industry Impact
Chapter 2 Global Nano-Silicon Drug Delivery Platform Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nano-Silicon Drug Delivery Platform (Volume and Value) by Type
2.3 Global Nano-Silicon Drug Delivery Platform (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Nano-Silicon Drug Delivery Platform Sales, Consumption, Export, Import by Regions
Chapter 5 North America Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 6 East Asia Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 7 Europe Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 8 South Asia Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 9 Southeast Asia Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 10 Middle East Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 11 Africa Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 12 Oceania Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 13 South America Nano-Silicon Drug Delivery Platform Market Analysis
Chapter 14 Company Profiles and Key Figures in Nano-Silicon Drug Delivery Platform Business
Chapter 15 Global Nano-Silicon Drug Delivery Platform Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837